Mind over migraine: therapy cuts headache days in new study
NCT ID NCT03461874
First seen Feb 20, 2026 · Last updated Jun 19, 2026 · Updated 14 times
Summary
This study tested whether adding Acceptance and Commitment Therapy (ACT) to standard migraine drugs could reduce monthly headache days in people with high-frequency episodic migraine (9-14 headache days per month). 64 adults were randomly assigned to either medication alone or medication plus 6 weekly group ACT sessions and 2 booster sessions. The main goal was to see if the ACT group had fewer headache days over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE WITHOUT AURA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fondazione IRCCS Istituto Neurologico C. Besta, Neuroalgology Unit
Milan, Milano, 20133, Italy
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.